Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Splanchnic Nerve Block for Acute Heart Failure
NCT02669407Completed
- Sponsor
- Duke University
- Start
- Jan 2017
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of lidocaine in acute heart failure (AHF), sponsored by Duke University. Primary endpoints: Central Venous Pressure at 90 months, Pulmonary Arterial Mean Pressure at 30 months and 1 more. Started Jan 2017; status: completed.
02
Drugs
lidocaine
03
Conditions
acute heart failure (AHF)
Beyond the preview
Go deeper on NCT02669407.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02669407.